| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | NEUTRAL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 2.17▼ | 2.14▼ | 2.13▼ | 2.06▲ | 2.31▼ |
| MA10 | 2.13▲ | 2.11▲ | 2.11▲ | 2.03▲ | 2.35▼ |
| MA20 | 2.10▲ | 2.12▲ | 2.18▼ | 2.30▼ | 1.96▲ |
| MA50 | 2.11▲ | 2.12▲ | 2.03▲ | 2.29▼ | 3.09▼ |
| MA100 | 2.19▼ | 2.14▼ | 2.28▼ | 1.91▲ | N/A |
| MA200 | 2.12▲ | 2.46▼ | 2.46▼ | 2.24▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.011▲ | 0.005▲ | -0.004▼ | -0.034▼ | 0.138▲ |
| RSI | 52.267▲ | 49.933▼ | 51.220▲ | 46.772▼ | 46.835▼ |
| STOCH | 65.855 | 73.414 | 49.949 | 24.897 | 47.660 |
| WILL %R | -44.444 | -42.105 | -42.105 | -64.151 | -56.608 |
| CCI | 30.915 | 80.964 | 31.362 | -21.294 | -3.760 |
|
Thursday, November 13, 2025 04:02 AM
Progressing Phase 2 studies for ratutrelvir, a ritonavir-free, protease inhibitor regimen in development for Acute and Long COVID with expected ...
|
|
Tuesday, October 28, 2025 06:56 AM
*Today’s High/Low is only updated during regular trading hours; and does not include trades occurring in pre-market or after-hours. Nasdaq Official Closing Price (NOCP) ist ein Prozess zur ...
|
|
Wednesday, October 22, 2025 11:40 AM
DOVER, Del., Oct. 22, 2025 /PRNewswire/ -- Expert Systems Inc., a leading life sciences accelerator, announced its continued support for Traws Pharma (NASDAQ: TRAW) as the company initiates Phase 2 ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 18/11/25 | 2.02 | 2.21 | 2.02 | 2.13 | 164,273 |
| 17/11/25 | 2.16 | 2.22 | 2.004 | 2.08 | 495,833 |
| 14/11/25 | 1.75 | 2.78 | 1.75 | 2.17 | 8,122,187 |
| 13/11/25 | 2.05 | 2.05 | 1.75 | 1.77 | 154,114 |
| 12/11/25 | 1.90 | 2.21 | 1.84 | 2.14 | 178,327 |
| 11/11/25 | 1.95 | 1.99 | 1.85 | 1.89 | 134,827 |
| 10/11/25 | 2.03 | 2.1888 | 1.91 | 1.94 | 87,041 |
| 07/11/25 | 2.01 | 2.05 | 1.90 | 1.95 | 89,819 |
| 06/11/25 | 2.17 | 2.1999 | 2.02 | 2.025 | 127,302 |
| 05/11/25 | 2.22 | 2.29 | 2.11 | 2.17 | 45,065 |
|
|
||||
|
|
||||
|
|